A randomized controlled study of treating chronic rhinosinusitis with macrolides.
- Author:
Yu LI
;
Tianjie WU
- Publication Type:Journal Article
- MeSH:
Anti-Bacterial Agents;
therapeutic use;
Cephalosporins;
therapeutic use;
Chronic Disease;
Humans;
Macrolides;
therapeutic use;
Rhinitis;
drug therapy;
Sinusitis;
drug therapy;
Treatment Outcome
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2014;28(17):1289-1291
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:Invastigation of macrolides in the treatment of drug effects in chronic rhinosinusit.
METHOD:The 165 patients with chronic rhinosinusit were randomly divided into 80 cases of macrolides drug group and 85 cases of cephalosporins group, and therapeutic effect was observed. The therapeutic effect of macrolides was also observed in refractory chronic rhinosinusit.
RESULT:Comparing macrolides group and cephalosporins group,there is not statistically significant (P > 0.05). Treatment with macrolides cefixime tablet ineffective treatment of patients for 3 months, compared before and after treatment was statistically significant (P < 0.01). Treatment with cefixime tablet macrolides ineffective treatment of patients for 3 months, compared before and after treatment was not statistically significant (P > 0.05).
CONCLUSION:Long-term low-dose applications of macrolides have a good effect in patients with chronic rhinosinusit, particularly for refractory chronic rhinosinusit have a significant effect.
